The entire conference will be translated into all languages (French, German, Spanish) simultaneously.

The program below is subject to change.

First Day October 20, 2023
Second Day October 21, 2023

Welcome by Dr. Gilbert Glady, President of the European Association of BioImmuneGenetic Medicine BI(G)MED) and creator of the method.

Prof. DAN PEER, PhD Tel Aviv UniversityPrecision nanomedicine laboratory   RNA-Lipid Nanoparticles 2.0: From gene silencing to genome editing A growing body of work is highlighting genes and signaling pathways that are impaired in human disorders and that may be potential candidates for treatment. The development of nucleic acid-based tools...

Prof. Andreas Weinhaeusel, PhD University of Natural Resources and Applied Life Sciences Vienna, Austria Epigenomics FOR improving minimal invasive cancer diagnostics Related keywords: minimal invasive cancer diagnostics, biomarker development, DNA methylation, liquid biopsy The minimal invasiveness of diagnostic procedures is a prerequisite to enable broad clinical application such as early...

Prof. Peré Gascón, MD PhD Institute of Science and Technology of Barcelona, SpainSpecialty: Oncology and Hematology INTEGRATIVE ONCOLOGY: AN ONCOLOGIST’S VISION  

Dr. Gilbert Glady, MD European Association for Immuno(g)enetic Biomedicine, France Dr. Narges Bahi-Jaber, PhD European Association of Immuno(G)enetic Biomedicine, France. Chronic EBV and autoimmune diseases – Standardization of serology with BI(G)MED

Presentation by different partner laboratories (TELETEST laboratory, NUGENIS laboratory and others) of new biological analyses useful in the diagnostic approach of BI(G)MED

Shopping cart0
There are no products in the cart!